Existing rp-haploinsufficient mutants may also be useful for determining if livers are more susceptible to drug-induced or metabolic stress; information that could help determine whether certain dietary or life-style factors or pharmacological interventions used in the clinical management of ribosomopathy patients increase their risk of developing liver disease. This evidence concerns the gene BLOC1S3 and liver disorder.